Cellebrite DI Ltd. (CLBT)
(Delayed Data from NSDQ)
$16.85 USD
-0.37 (-2.12%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $16.86 +0.01 (0.06%) 6:38 PM ET
2-Buy of 5 2
D Value A Growth D Momentum C VGM
Price, Consensus and EPS Surprise
CLBT 16.85 -0.37(-2.12%)
Will CLBT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CLBT based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CLBT
Is Exponent (EXPO) Stock Outpacing Its Business Services Peers This Year?
Are Business Services Stocks Lagging Adyen (ADYEY) This Year?
CLBT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why Cellebrite DI Ltd. (CLBT) Might be Well Poised for a Surge
Is Cellebrite DI Ltd. (CLBT) Stock Outpacing Its Business Services Peers This Year?
Cellebrite DI Ltd. (CLBT) Soars to 52-Week High, Time to Cash Out?
Other News for CLBT
Cellebrite Patents its Remote Mobile Collection Capabilities for Businesses
Cellebrite Announces Results of Completed Redemption of All Outstanding Warrants
Cellebrite Completes Warrant Redemption Process
Cellebrite participates in a conference call with Craig-Hallum
Cellebrite participates in a conference call with Craig-Hallum